Hodgkin Lymphoma is a hematologic malignancy of mature B cells originating in the lymphatic system, characterized by the presence of Reed Sternberg cells.
Non-Hodgkin Lymphoma is a hematologic malignancy of mature B cells originating in the lymphatic system, characterized by the absence of Reed Sternberg cells.
Reed Sternberg cells are multi-nucleated cells, usually binucleated, with two nuclei fused together and the two nuclei next to each other, appearing like allies.
ABVD is a common regimen used for Hodgkin lymphoma, which includes adreomycin, bleomycin, vinblastine, and decarbazine, and is usually carried out for three to four cycles and followed by radiation therapy.
Burkitt lymphoma is a highly aggressive subtype of non-hodgkin lymphoma, and if a biopsy is performed on these patients, it will be described as a starry sky appearance due to nume.
Diffuse large B cell is the most common subtype of non-hodgkin lymphoma, accounts for around 25 percent of adult non-hodgkin cases, and is very aggressive and fast growing.
Hodgkin lymphoma is a malignancy of B cells originating in the lymphatic system, characterized by B symptoms, and has a better prognosis when it is localized and does not involve the lungs.
Hodgkin Lymphoma has a better prognosis because it normally doesn't spread very far, unlike Non-Hodgkin Lymphoma which can spread quickly to other parts of the body.
In an immunocompetent patient, Hodgkin lymphoma is not common, but in patients with HIV/AIDS or other immunosuppressive conditions, almost all Hodgkin lymphoma cases are EBV positive.
In patients with Hodgkin lymphoma, the lymph nodes are normally non-tender, but if these patients drink even a small amount of alcohol, the lymph nodes become painful.